- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07939386
Comparison of the Effect of Lung-protective Ventilation on Optic Nerve Sheath Diameter in Obese and Non-obese Patients
Comparison of the Effect of Recruitment Maneuver and Individualized Positive End-expiratory Pressure on Optic Nerve Sheath Diameter in Obese and Non-obese Patients Undergoing Laparoscopic Surgery
The gol of this prospective observational study is to evaluate the effect of recruitment maneuvers-employed as part of an intraoperative lung-protective ventilation strategy-and individualized positive end-expiratory pressure (PEEP) on intracranial pressure, as assessed by measuring the optic nerve sheath diameter, in both obese and non-obese patients undergoing laparoscopic surgery.
Study Overview
Status
Conditions
Detailed Description
Laparoscopy is widely used due to its advantages, such as less blood loss, reduced postoperative pain, and faster recovery. However, pneumoperitoneum increases thoracoabdominal pressure, which decreases venous drainage from the brain and increases cerebral blood flow and intracranial pressure (ICP). The optic nerve sheath diameter (ONSD) measurement via ultrasound is a non-invasive and reliable method for assessing ICP.
The prevalence of obesity has increased substantially over recent decades, accompanied by a growing number of obese patients undergoing laparoscopic surgery. Obesity is associated with increased intra-abdominal pressure, which may contribute to an increase in ONSD. Furthermore, the additional rise in intra-abdominal pressure induced by pneumoperitoneum may exacerbate these effects, potentially placing obese patients at greater risk of alterations in cerebral haemodynamics during laparoscopic procedures.
Atelectasis occurs in roughly 90% of all patients undergoing general anaesthesia and can persist for weeks after operation. Intraoperative lung-protective ventilation has been recommended to reduce postoperative pulmonary complications after abdominal and/or laparoscopic surgery and also in obese patients. Decreasing compliance caused by surgical/ anaesthesia factors (i.e. pneumoperitoneum, positioning, and circuit disconnect) should be treated by appropriate interventions. Individualised PEEP and alveolar recruitment manoeuvres can prevent and reverse alveolar collapse, respectively.
However, the effects of these interventions on cerebral haemodynamics, particularly ICP as assessed indirectly by ONSD measurement, remain insufficiently understood in obese and non-obese patients undergoing laparoscopic surgery.
The gol of this prospective observational study is to evaluate the effect of recruitment maneuvers and individualized PEEP- as part of intraoperative lung-protective ventilation strategy- on intracranial pressure, as assessed by measuring the optic nerve sheath diameter (ONSD), in both obese and non-obese patients undergoing laparoscopic surgery.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Gulay Erdogan Kayhan, Prof. Dr.
- Phone Number: 905332560011
- Email: drgulayer@yahoo.com
Study Contact Backup
- Name: Muhammed Alpaslan Uludag, Research Assistant, MD
- Email: muho.78@live.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients over 25 years of age
- American Soc,ety of Anesthesiology (ASA) status I-III
- Scheduled to undergo laparoscopic abdominal surgery
- With an expected pneumoperitoneum duration of ≥1 hour
Exclusion Criteria:
- Patients with ocular disease
- Patients who have undergone cranial or ocular surgery
- Patients with a history of laparotomy
- Individuals with bullous lung disease
- Patients with uncontrolled chronic obstructive lung disease
- Patients with hemodynamic instability or decompensated heart failure
- Patients who require conversion to an open surgical procedure for any reason
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Group O
Obese patients with BMI ≥ 30 kg/m² |
Following intubation and desufflation, an incremental alveolar recruitment maneuver (ARM) will be performed, in which the driving pressure is kept constant while the PEEP value is increased in a stepwise manner. The ARM will be performed in pressure control mode, maintaining pressure at a steady driving pressure with increments in PEEP until a peak pressure is achieved (35-40 cmH2) with a preestablished maximum PEEP. This will be maintained long enough to reopen the alveoli (5---10 breaths), and then pressure is reduced in a stepwise manner until the ideal PEEP is achieved (this being the PEEP level that produces the best Cdyn at the lowest driving pressure for a particular tidal volume setting) ONSD will be measured at a standard level of 3 mm behind using a lineer ultrasound transducer. The measurements will be performed by an anesthesiologist experienced in ONSD measurement. The eyes will be covered with drapes; subsequently, using an ultrasound-compatible gel, measurements of both of the patient's eyes will be taken in a transverse and a sagittal plane. The mean of these measurements will then be calculated to determine the ONSD value. |
|
Other: Group N
Non-obese patients |
Following intubation and desufflation, an incremental alveolar recruitment maneuver (ARM) will be performed, in which the driving pressure is kept constant while the PEEP value is increased in a stepwise manner. The ARM will be performed in pressure control mode, maintaining pressure at a steady driving pressure with increments in PEEP until a peak pressure is achieved (35-40 cmH2) with a preestablished maximum PEEP. This will be maintained long enough to reopen the alveoli (5---10 breaths), and then pressure is reduced in a stepwise manner until the ideal PEEP is achieved (this being the PEEP level that produces the best Cdyn at the lowest driving pressure for a particular tidal volume setting) ONSD will be measured at a standard level of 3 mm behind using a lineer ultrasound transducer. The measurements will be performed by an anesthesiologist experienced in ONSD measurement. The eyes will be covered with drapes; subsequently, using an ultrasound-compatible gel, measurements of both of the patient's eyes will be taken in a transverse and a sagittal plane. The mean of these measurements will then be calculated to determine the ONSD value. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Optic nerve sheath diameter (ONSD)
Time Frame: Perioperative/Periprocedural (t0-after anesthesia induction and entubation)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t0-after anesthesia induction and entubation)
|
|
Optic nerve sheath diameter (ONSD)
Time Frame: Perioperative/Periprocedural (t1- following the recruitment maneuver and the adjustment of the individualized PEEP value)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t1- following the recruitment maneuver and the adjustment of the individualized PEEP value)
|
|
Optic nerve sheath diameter (ONSD)
Time Frame: Perioperative/Periprocedural (t2- at the 30th minute of pneumoperitoneum)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t2- at the 30th minute of pneumoperitoneum)
|
|
Optic nerve sheath diameter (ONSD)
Time Frame: Perioperative/Periprocedural (t3 - after desufflation)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t3 - after desufflation)
|
|
Optic nerve sheath diameter (ONSD)
Time Frame: Perioperative/Periprocedural (t4- following a subsequent recruitment maneuver)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t4- following a subsequent recruitment maneuver)
|
|
Optic nerve sheath diameter (ONSD)
Time Frame: Perioperative/Periprocedural (t5- at the 30th minute in the recovery room)
|
Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound |
Perioperative/Periprocedural (t5- at the 30th minute in the recovery room)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MAP
Time Frame: Perioperative (Noninvasive mean arterial pressure will be recorded at the times when ONSD measurement is performed)
|
Noninvasive mean arterial pressure (mmHg) |
Perioperative (Noninvasive mean arterial pressure will be recorded at the times when ONSD measurement is performed)
|
|
HR
Time Frame: Perioperative (Heart rate will be recorded at the times when ONSD measurement is performed)
|
Heart rate (beat/min) |
Perioperative (Heart rate will be recorded at the times when ONSD measurement is performed)
|
|
etCO2
Time Frame: Perioperative (End-tidal carbon dioxide levels will be recorded at the times when ONSD measurement is performed)
|
End-tidal carbon dioxide levels (mmHg) |
Perioperative (End-tidal carbon dioxide levels will be recorded at the times when ONSD measurement is performed)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Airway pressures during mechanical ventilation
Time Frame: Perioperative (Ppeak, Pplato, Driving pressure (∆P), PEEP levels will be recorded at the times when ONSD measurement is performed)
|
Ppeak, Pplato, Driving pressure (∆P), PEEP levels (cmH20) will be recorded from the sama ventilation monitor screen |
Perioperative (Ppeak, Pplato, Driving pressure (∆P), PEEP levels will be recorded at the times when ONSD measurement is performed)
|
|
Postoperative complications
Time Frame: PONV will be questioned at the 24th hours
|
Postoperative nause and vomiting (PONV) |
PONV will be questioned at the 24th hours
|
|
Postoperative complications
Time Frame: Headache will be questioned at the 24th hours
|
Headache |
Headache will be questioned at the 24th hours
|
|
Postoperative complications
Time Frame: Visual disturbance will be questioned at the 24th hours
|
Visual disturbance |
Visual disturbance will be questioned at the 24th hours
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-25403353-050.04-260108454
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.